Serum cystatin C is correlated with mortality of traumatic brain injury patients partially mediated by acute kidney injury.
Serum cystatin C is correlated with mortality of traumatic brain injury patients partially mediated by acute kidney injury.
复制标题
DOI:
10.1007/s13760-023-02282-2
复制
发表时间:
2023-12
影响因子:
2.7
通讯作者:
Xu, Jianguo
中科院分区:
文献类型:
--
作者:
Wang, Ruoran;Chen, Hongxu;He, Min;Xu, Jianguo
Evaluating risk of poor outcome for Traumatic Brain Injury (TBI) in early stage is necessary to make treatment strategies and decide the need for intensive care. This study is designed to verify the prognostic value of serum cystatin C in TBI patients. 415 TBI patients admitted to West China hospital were included. Logistic regression was performed to explore risk factors of mortality and testify the correlation between cystatin C and mortality. Mediation analysis was conducted to test whether Acute Kidney Injury (AKI) and brain injury severity mediate the relationship between cystatin C level and mortality. Area under the receiver operating characteristic curve (AUC) was used to evaluate the prognostic value of cystatin C and the constructed model incorporating cystatin C. The mortality rate of 415 TBI patients was 48.9%. Non-survivors had lower GCS (5 vs 8, p < 0.001) and higher cystatin C (0.92 vs 0.71, p < 0.001) than survivors. After adjusting confounding effects, multivariate logistic regression indicated GCS (p < 0.001), glucose (p < 0.001), albumin (p = 0.009), cystatin C (p < 0.001) and subdural hematoma (p = 0.042) were independent risk factors of mortality. Mediation analysis showed both AKI and brain injury severity exerted mediating effects on relationship between cystatin C and mortality of included TBI patients. The AUC of combining GCS with cystatin C was 0.862, which was higher than that of GCS alone (Z = 1.7354, p < 0.05). Both AKI and brain injury severity are mediating variables influencing the relationship between cystatin C and mortality of TBI patients. Serum cystatin C is an effective prognostic marker for TBI patients.
登录
查看更多内容
影响因子:
4.6
作者:
Chen D;Sun W;Li J;Wei B;Liu W;Wang X;Song F;Chen L;Yang J;Yu L
通讯作者:
Yu L
影响因子:
1.1
作者:
Ahmed, Masud;Sriganesh, Kamath;Rao, Ganne S. Umamaheswara
通讯作者:
Rao, Ganne S. Umamaheswara
影响因子:
6.7
作者:
Maiwall, Rakhi;Kumar, Awinash;Sarin, Shiv K.
通讯作者:
Sarin, Shiv K.
影响因子:
13.2
作者:
Coll, E;Botey, A;Darnell, A
通讯作者:
Darnell, A
影响因子:
8
作者:
Fabjan, Tanja Hojs;Penko, Meta;Hojs, Radovan
通讯作者:
Hojs, Radovan